Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology
Prevalence of Rett syndrome
9 evidence topics · 12 sources
Global pooled prevalence in females: systematic review and meta-analysis
“We conducted a search of PubMed, Embase, Web of Science, Cochrane Library, LILACS, and LIVIVO to retrieve studies published in English between Jan. 1, 2000, and June 30, 2021. Pooled prevalence with a 95% confidence interval (CI) was estimated using a random-effects meta-analysis based on a generalized linear mixed model with a logit link.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Ten eligible studies were identified (all in females), with a combined sample size of 9.57 million women and 673 Rett syndrome cases. The pooled prevalence estimate (random effects) was 7.1 per 100,000 females (95% CI: 4.8, 10.5, heterogeneity p < 0.001). Despite greatly variable precision of estimation, all estimates were compatible with a prevalence range of approximately 5 to 10 cases per 100,000 females based on their respective 95% CIs.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Study-specific prevalence estimates per 100,000 females (95% CI) ranged from 0.0 (0.0, 8.8) to 38.3 (4.6, 138.0), with a highly significant heterogeneity test (p < 0.001, I2 = 0.831).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“No studies that included patients with RTT older than 35 years were included.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Worldwide prevalence per female births: reference estimates
Australia: point prevalence by age group
“The point prevalence of RTT in Australia on the 31st June 2009 was 8.6 per 100,000 females (95% CI 7.4-10.1) aged five to 18 years and 5.8 per 100,000 females (95% CI 4.8-6.9) aged 19 years to 32 years.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Serbia: prevalence in females younger than 19 years
United States: annual prevalence of diagnosis in claims data, 2016 to 2019
“The annual prevalence of RTT between November 1, 2016 and October 31, 2019 in this dataset ranged from 0.30–0.32 per 10,000 enrollees overall, with higher prevalence ranges observed among female than male patients (female: 0.45–0.52; male: 0.08–0.10; Table 1).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Annual prevalence was calculated as the proportion of patients with a diagnosis of RTT among the total number of patients enrolled in the IQVIA Dx and LRx databases.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote